Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis
Abstract Berberine (BBR) has been explored as a potential anti-liver fibrosis agent, but the underlying mechanisms are unknown. In the current study, we aimed to investigate the molecular mechanisms underlying the effect of BBR against liver fibrogenesis in thioacetamide (TAA) and carbon tetrachlori...
Saved in:
Main Authors: | Jiazhi Yi, Shuyun Wu, Siwei Tan, Yunfei Qin, Xing Wang, Jie Jiang, Huiling Liu, Bin Wu |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e20b2c9dbc22437d8bca7f0f63a74de5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging Pathological Engagement of Ferroptosis in Gut Diseases
by: Weihua Gao, et al.
Published: (2021) -
γ-Glutamylcysteine Alleviates Ischemic Stroke-Induced Neuronal Apoptosis by Inhibiting ROS-Mediated Endoplasmic Reticulum Stress
by: Hui-qin Li, et al.
Published: (2021) -
Exploration of Redox-Related Molecular Patterns and the Redox Score for Prostate Cancer
by: Yue Wu, et al.
Published: (2021) -
Initiation of hepatic stellate cell activation extends into chronic liver disease
by: Vincent De Smet, et al.
Published: (2021) -
Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury
by: Xinye Li, et al.
Published: (2021)